Schwartz PE - Search Results

1

Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.

Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers SK, Secord AA, Havrilesky L, O'Malley DM, Backes F, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi KS, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Fader AN, et al. Among authors: schwartz pe. J Clin Oncol. 2018 Jul 10;36(20):2044-2051. doi: 10.1200/JCO.2017.76.5966. Epub 2018 Mar 27. J Clin Oncol. 2018. PMID: 29584549 Clinical Trial.

2

Ovarian germ cell malignancies: the Yale University experience.

Schwartz PE, Chambers SK, Chambers JT, Kohorn E, McIntosh S. Schwartz PE, et al. Gynecol Oncol. 1992 Apr;45(1):26-31. doi: 10.1016/0090-8258(92)90486-3. Gynecol Oncol. 1992. PMID: 1376294 No abstract available.

3

Ovarian cancer staging: does it require a gynecologic oncologist?

Mayer AR, Chambers SK, Graves E, Holm C, Tseng PC, Nelson BE, Schwartz PE. Mayer AR, et al. Among authors: schwartz pe. Gynecol Oncol. 1992 Nov;47(2):223-7. doi: 10.1016/0090-8258(92)90110-5. Gynecol Oncol. 1992. PMID: 1468701 Free article.

4

Sequelae of lateral ovarian transposition in unirradiated cervical cancer patients.

Chambers SK, Chambers JT, Holm C, Peschel RE, Schwartz PE. Chambers SK, et al. Among authors: schwartz pe. Gynecol Oncol. 1990 Nov;39(2):155-9. doi: 10.1016/0090-8258(90)90424-j. Gynecol Oncol. 1990. PMID: 2121629 Clinical Trial.

5

Correlation between measured creatinine clearance and calculated creatinine clearance in ovarian cancer patients.

Chambers JT, Chambers SK, Schwartz PE. Chambers JT, et al. Among authors: schwartz pe. Gynecol Oncol. 1990 Jan;36(1):66-8. doi: 10.1016/0090-8258(90)90110-7. Gynecol Oncol. 1990. PMID: 2295454

6

Neoadjuvant chemotherapy in stage X ovarian carcinoma.

Chambers JT, Chambers SK, Voynick IM, Schwartz PE. Chambers JT, et al. Among authors: schwartz pe. Gynecol Oncol. 1990 Jun;37(3):327-31. doi: 10.1016/0090-8258(90)90361-n. Gynecol Oncol. 1990. PMID: 2351315

7

Neutropenia and fever in patients undergoing combination chemotherapy for malignant germ cell tumors of the ovary.

Chambers SK, Schwartz PE. Chambers SK, et al. Among authors: schwartz pe. Obstet Gynecol. 1986 Dec;68(6):842-6. Obstet Gynecol. 1986. PMID: 2431369

8

Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity.

Chambers SK, Flynn SD, Del Prete SA, Chambers JT, Schwartz PE. Chambers SK, et al. Among authors: schwartz pe. Gynecol Oncol. 1989 Mar;32(3):303-9. doi: 10.1016/0090-8258(89)90629-x. Gynecol Oncol. 1989. PMID: 2465939

9

Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasms.

Kacinski BM, Stanley ER, Carter D, Chambers JT, Chambers SK, Kohorn EI, Schwartz PE. Kacinski BM, et al. Among authors: schwartz pe. Int J Radiat Oncol Biol Phys. 1989 Jul;17(1):159-64. doi: 10.1016/0360-3016(89)90383-0. Int J Radiat Oncol Biol Phys. 1989. PMID: 2663797 Free article.

10

Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer.

Chambers SK, Chopyk RL, Chambers JT, Schwartz PE, Duffy TP. Chambers SK, et al. Among authors: schwartz pe. Cancer. 1989 Dec 15;64(12):2459-61. doi: 10.1002/1097-0142(19891215)64:12<2459::aid-cncr2820641210>3.0.co;2-t. Cancer. 1989. PMID: 2819655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters